A recall was issued for two lots of Baxter 0.9% sodium chloride injection after fiberglass particulate was identified as potentially present, although the claim overstates the scope and certainty of the finding.
A recall has been issued for IV saline injections because they were contaminated with fiberglass.

Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter | FDA
Source: fda.gov
Key Evidence
The FDA directly reported a voluntary nationwide recall of two Baxter lots of 0.9% sodium chloride injection because of the potential presence of fiberglass particulate matter.
The recall was limited to specified lots, and the FDA wording described a potential presence rather than confirming that all units were contaminated.
Other cited saline and injection recalls involved different products or hazards, including sterility concerns, leaking containers, unspecified particles and veterinary medication.
What the Evidence Shows
The FDA announced a voluntary nationwide recall of two lots of Baxter 0.9% sodium chloride injection because of the potential presence of fiberglass particulate matter in the solution. The agency warned that exposure could cause serious adverse health consequences. This supports the core claim that an IV saline product was recalled in connection with fiberglass, but the recall applied to specific lots, not all IV saline injections.fda.govfda.govBaxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride... The wording also matters. The FDA described the issue as a potential presence of particulate matter identified as fiberglass, rather than establishing that every recalled injection was confirmed to contain fiberglass. The available sources describe other saline recalls for different problems, including possible loss of sterility, leaking containers, missing port protectors and unspecified particulate contamination. Those incidents should not be combined into one fiberglass-contamination event.
drugs.comdrugs.comNormal Saline Flush Safety Alerts, Recalls & Warnings+4 more
Some of the search results concern unrelated products. A 2018 recall involved contaminated IV saline flush syringes, while recent reports described fiberglass in Adequan joint injections for dogs and horses, not human IV saline. A Medical Daily report also described downstream recalls involving kits that contained a recalled saline ampule, but that does not broaden the original FDA action to every saline product.empr.comempr.comClass I Recall Issued for Contaminated IV Saline Flush Syringes
goodhousekeeping.comgoodhousekeeping.comNationwide Recall Issued for Popular Dog Joint Medication Over Glass Fiber...+2 more
The claim is therefore accurate in its central point, but it lacks the important lot-specific limitation and presents a potential presence as a confirmed blanket contamination. The most precise description is that Baxter recalled two lots of IV saline because fiberglass particulate might be present.
Verified Sources10
Recall of Certain Saline and Sterile Water Medical Products Associated with...
Class I Recall Issued for Contaminated IV Saline Flush Syringes
Revision history
- Version 2August 27, 2026
The fresh result is supported by a high-reliability FDA source directly documenting a voluntary nationwide recall of two lots of Baxter 0.9% sodium chloride injection because fiberglass particulate could potentially be present. This changes the best-supported verdict from Misleading to Mostly True. The claim still requires material qualification: it concerns a specific Baxter IV saline product and two lots, and the FDA described a potential presence of fiberglass rather than confirming contamination in every recalled unit.
Misleading → Mostly True - Version 1August 27, 2026
Initial published version
Misleading